Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study. (2015)

First Author: Huizinga TW
Attributed to:  Infrastructure for collaboration: Leeds MRC Medical Bioinformatics Centre funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2014-205752

PubMed Identifier: 25169728

Publication URI: http://europepmc.org/abstract/MED/25169728

Type: Journal Article/Review

Volume: 74

Parent Publication: Annals of the rheumatic diseases

Issue: 1

ISSN: 0003-4967